Mission
Our mission is to develop novel monoclonal antibodies and monoclonal antibody-drug conjugates (ADCs) to treat cancer and provide novel therapeutics for unmet medical needs.
Read More
Pipeline
Agensys is progressing a pipeline of both naked and antibody-drug conjugated (ADC) therapeutic antibodies, directed at a variety of cancer indications.
Read More
Careers
Agensys offers a wealth of career opportunities in a wide range of areas from science and research to administration.
Read More
